A recently opened double- blind phase III EORTC trial 1325 will prospectively assess whether post-operative adjuvant therapy with pembrolizumab, an anti-PD-1 monoclonal antibody, improves recurrence-free survival as compared ...
One in four middle-aged adults who survive to age 85 will develop heart failure, according to current estimates. Intervention programs to improve lifestyles are widely advocated, but do they actually work? Investigators in ...
The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.
A 16-year-old girl in Sierra Leone has died from Ebola, dealing a blow to optimism that the west African country has finally turned the page on the devastating epidemic.
A new study finds that the characteristics of one's community may be as important as individual factors on the decision to become an organ donor. The study, published in The Milbank Quarterly, shows an association between ...
Malnutrition is a known complication of weight loss surgery, but findings from a small study by researchers at Johns Hopkins show many obese people may be malnourished before they undergo the procedure.
Revealing a biological combat strategy worthy of a five-star general, researchers from Houston Methodist Hospital, University of Chicago and Cornell University have shown how a cell surface receptor—a specialized protein ...
Optogenetics is a quickly expanding field of research which has revolutionized neurobiological and cellbiological research around the world. It uses natural or tailored light-sensitive proteins in order to switch nerve cells ...
Protein NBS1, which plays a key role in DNA damage repair, is required for macrophage functional activity. This is one of the conclusions of a scientific paper published in the journal Blood by a team of experts from the ...